Globus Medical shares rise following EU approval of imaging system

Revelation News Editorial DeskSeptember 3, 2026

Source Summary

Globus Medical's stock price increased following European Union regulatory approval for one of its imaging systems. The approval represents a regulatory milestone for the medical device company's product portfolio.

Why it matters

EU regulatory approval expands the company's addressable market and validates its imaging technology for European medical institutions.

Read the Source

Investing.com ↗

NYSE:GMEDLive chart

Trading trends

The chart totals every SEC-reported transaction by month and share count, separating informative purchases and sales from non-informative awards, vesting, exercises, tax withholding and transfers. Records without a reported price remain included. Only informative purchases and sales affect the conservative sentiment signal.

Recent SEC-reported share and derivative transactions in GLOBUS MEDICAL INC.

Insider activity sentiment

Bearish

BearishNeutralBullish

0 discretionary purchases · 2 discretionary sales

Confidence: Medium

Informative buyNon-informative buyInformative sellNon-informative sell

Insiders	Activity	Description	Shares	Avg. price / share	Est. value	Trade date
DirectorTOBIN JAMES R	Informative sell	Class A Common StockOpen-market or private transaction (S)	30,000	$74.5834	$2,237,502	Sep 15, 2026
DirectorTOBIN JAMES R	Non-informative buy	Class A Common StockExercise or conversion; not an open-market trade (M)	30,000	—	—	Sep 15, 2026
DirectorZARRILLI STEPHEN T	Informative sell	Class A Common StockOpen-market or private transaction (S)	25,000	$87.0386	$2,175,965	Aug 18, 2026
DirectorZARRILLI STEPHEN T	Non-informative buy	Class A Common StockExercise or conversion; not an open-market trade (M)	25,000	—	—	Aug 18, 2026
DirectorDavidar David D	Non-informative sell	Class A Common StockGift or transfer (G)	2,500	—	—	Jul 27, 2026

As filed with the SEC. Estimated value is shown only for purchases or sales with a positive reported transaction price; awards, gifts and similar activity are not assigned an assumed market value. Amendments may change the record. This is not investment advice.

Short interest

Open short positions reported twice monthly; this is not daily short-sale volume.

Earnings

Recent reported earnings per share compared with the analyst consensus available from Nasdaq.

Comments

No published comments yet.

Owner	Activity	Change	Shares held	Value (thousands)	Reported
Blackrock, Inc.	Buy	309,310 (2.947%)	10,806,724	$882,477	6/30/2026
Vanguard Group Inc	Sell	-56,292 (-0.531%)	10,549,455	$861,468	12/31/2025
Jupiter Topco Llc	Buy	8,200,423 (New)	8,200,423	$669,647	6/30/2026
Janus Henderson Group Ltd.	Buy	328,217 (4.499%)	7,623,095	$622,502	3/31/2026
Vanguard Capital Management Llc	Buy	74,800 (1.486%)	5,107,532	$417,081	6/30/2026
Vanguard Portfolio Management Llc	Buy	114,926 (2.355%)	4,994,385	$407,841	6/30/2026
Invesco Ltd.	Sell	-6,883 (-0.159%)	4,309,771	$351,936	6/30/2026
Kayne Anderson Rudnick Investment Management Llc	Buy	4,279,730 (New)	4,279,730	$349,483	6/30/2026
State Street Corp	Buy	123,657 (3.444%)	3,714,029	$303,288	6/30/2026
Sculptor Capital Lp	Sell	-58,000 (-1.897%)	3,000,000	$244,980	6/30/2026
Jpmorgan Chase & Co	Buy	148,542 (5.723%)	2,743,850	$224,063	6/30/2026
Bank Of Montreal /Can/	Buy	118,310 (5.128%)	2,425,491	$198,066	6/30/2026

Settlement date	Short interest	Avg. daily volume	Change vs. previous report	Days to cover
Sep 30, 2026	8,437,114	1,640,932	+24.67%	5.14
Sep 15, 2026	6,767,512	1,469,890	+2.22%	4.60
Aug 31, 2026	6,620,718	1,013,754	-2.67%	6.53
Aug 14, 2026	6,802,529	1,721,196	-1.22%	3.95
Jul 31, 2026	6,886,644	1,409,379	-2.58%	4.89
Jul 15, 2026	7,069,160	2,018,657	-4.60%	3.50
Jun 30, 2026	7,409,990	2,079,068	+35.48%	3.56
Jun 15, 2026	5,469,519	1,595,502	+39.65%	3.43

Fiscal quarter	Reported	EPS	Consensus	Surprise
Jun 2026	Aug 6, 2026	1.34	1.12	+19.64%
Mar 2026	May 7, 2026	1.12	0.92	+21.74%
Dec 2025	Feb 24, 2026	1.28	1.06	+20.75%
Sep 2025	Nov 6, 2025	1.18	0.79	+49.37%

Source Summary

Why it matters

Read the Source

NYSE:GMED — Live chart

Insider activity sentiment

Comments

Related stories

Olympus shares fall to 12-week low following FDA quality systems warning

FDA: Edwards Lifesciences Withdraws Valve Delivery System After Balloon Ruptures

U.S. Energy Regulators Propose Expedited Approval Process for LNG Export Expansions

Comments

Insider activity sentiment

NYSE:GMEDLive chart